📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial. (2020)

First Author: Freeman TP
Attributed to:  Cannabidiol: a novel treatment for cannabis dependence? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2215-0366(20)30290-x

PubMed Identifier: 32735782

Publication URI: http://europepmc.org/abstract/MED/32735782

Type: Journal Article/Review

Volume: 7

Parent Publication: The lancet. Psychiatry

Issue: 10

ISSN: 2215-0366